Latest News - Biotech - United States

Multiple Therapy System 7 unites state-of-the-art treatment in a single, handheld therapy MTS7device to speed rehabilitation and recovery of animals. MTS7, seven therapies in one easy-to-use device, results in quicker treatment and faster recovery.

AnaSpec has announced the launch of the industry’s first FRET-based thrombin assay – the SensoLyteÒ 520 Thrombin Activity Assay Kit.

A herpes virus better known for causing cold sores has shown promise as a treatment for late-stage skin cancer, according to research presented at the American Society of Gene Therapy’s 12th Annual Meeting, May 27.

In the past 20 years, gene therapy has advanced from concept to effective clinical application, according to a presentation at the American Society of Gene Therapy’s 12th Annual Meeting, May 27.

By adding new software and a real camera, the LapSim laparoscopic training system allows realistic team training.

Experigen Expands Services To Include Technology Assessment and Technology Development

Stellar Slate of Leaders Joined by Biotech and Pharma Supply Chain Executives and Educators

Cool View LLC hopes to combine the green of profitability and the green of environmental responsibility in the world’s first line of LED surgical lighting products.

Leading Risk Management Experts to identify Solutions to Biotech Supply and Product Disruptions in Groundbreaking Webinar on June 18

Biodiesel Market Potential is a complete guide to help assess the feasibility of this alternative fuel source.

GenScript will sponsor the BIT Life Sciences’ 1st Annual International Congress of Antibodies (ICA). CEO Dr. Frank Zhang will give keynote speech to share thoughts on antibody drug development.

Biomedical news portal profiles 11 companies with FDA decisions pending. Complete report released in detail today at BiomedReports.Com.

Voobon Ventures has expressed a great interest in partnering with Kalos Therapeutics, founder of the patented cancer treatment, KT-220 ANP.

Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery.

AnaSpec has introduced a wide selection of membrane potential fluorescent probes.

Akronite forms partnership with job search engine Simply Hired to create to a powerful green jobs platform

Most people want to know what they can do to make their dollar go further, particularly when purchasing household appliances.

Pharmaceutical Sales Representative (College Overhire) - 2009 - United States: Johnson & Johnson Family of Companies

The five drugs that accounted for the most dispensed scrips include four generics and just one branded product--and that brand saw scrips drop

In the first such online community of its kind, Advanced Bionics, the only U.S.-based manufacturer of “bionic ears”, is connecting cochlear recipients and candidates from across the country through its new “Connect to Mentor” Web site.

National Business Brokerage is pleased to announce its affiliation with Exit Realtyof Little Rock, Arkansas. National Business Brokerage is a business brokerage firm that has a division specializing in the buying and selling of biodiesel plants..

Michael Jenkins, PhD, general manager of Catalent’s Middleton, WI facility, will present at the BIO Process Theatre of the 2009 BIO International Convention. His talk will focus on Catalent’s GPEx technology for mammalian cell line engineering.

The American Civil Liberties Union action in filing a lawsuit yesterday against Myriad Genetics is going to lead to one of the most important legal battles in the history of biotechnology, asserts Genetic Engineering & Biotechnology News (GEN).

The most valuable asset in your business today is not capital but your employees and customers. Tough times mean focusing on what matters most which is staying close to your customers and retaining them profitably.

Two Catalent scientists, Dr. Tom Feinberg, director of structural chemistry services, and Dr. Craig Davies-Cutting, director of research and development, will host a 45-minute interactive workshop at RDD Europe 2009.

Biosearch Technologies, Inc. (Biosearch), a manufacturer of fluorogenic probes and primers, DNA/RNA synthesis reagents, and immunochemicals, today announced that it has launched a new website, www.biosearchtech.com.

Biosearch Technologies, Inc. has responded to the swine influenza pandemic, also known as 2009 H1N1, by offering the synthesis of all research use only oligonucleotide probes and primers composing the swine flu detection panel disclosed by the CDC.

MILWAUKEE – The Society for Clinical Data Management today reached an important milestone with the certification of its 400th Certified Clinical Data Manager (CCDM®).

Market Research Media announces a new study "Global Pandemic Influenza Preparedness Market Forecast 2010-2015"

Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009.

AnaSpec has introduced a line of b-amyloid peptides labeled with biotin (N or C-terminal biotin labels) as well as N-terminal biotin labeled b-amyloid peptides with a fluorescein label on the C-terminus.

At a recent press conference, Sustainable Now Technologies (SNT) announced the appointment of their third officer.

The report on the Biomass to Biofuels Market Potential is a complete guide to help assess the feasibility of domestic and international production of biofuels.

The Zimmerman Group, award-winning marketing/consulting firm, was signed by BioChemed Services to handle strategic planning, direct marketing, trade show design and promotion, web enhancement, and client/prospect communications.

BIOTRONIK Inc. announced today the U.S. launch of its Lumax 540 series, technologically advanced devices using industry-leading features to save and enhance patients’ lives.

BIOTRONIK Inc. introduced today the Lumax 540 with all-new pacing technology features, reaffirming the company’s technological leadership in heart monitoring devices.

Study Investigates Use of Remote Monitoring to Reduce Risk of Strokes in Patients with Atrial Fibrillation

Agency Develops Logo and Packaging for New Product

2009 marks the 20 year anniversary of BioPlus Specialty Pharmacy

Disc Motion Technologies, the First Company to Commercialize the Posterior Total Arthroplasty System for the Lumbar Spine, Announces the First Surgical Procedure Using Inlign™ MLH System- Combining Fusion and Arthroplasty in One Integrated System.

Publisher Mary Ann Liebert, Inc. (www.liebertpub.com), will provide free online access to all issues of its authoritative, peer-reviewed publication Journal of Women's Health for the entire month of May in recognition of National Women's Health Week.

Biodiesel design and engineering company, announces new Biodiesel Laboratory and Piloting Services.

Biodeisel Plant Manufacturer, AP Innovations Selects Lee Enterprises to Market Biodiesel Their Plants Worldwide

National Business Brokerage, Inc., a full service business brokerage firm in Little Rock, Arkansas is pleased to announce its biodiesel plant sales division.

Green Technologies Corporation, Sustainable Now Technologies (SNT), announces the launch of it's official company website.

MedArray, a specialty membrane and device manufacturer, announces the availability of its PermSelect® Silicone Hollow Fiber Membrane Modules.

GenScript offers high quality bundled bio-reagent samples to appreciate customers and assist in biology research under current tough economic condition.

AnaSpec has announced the launch of the Z-Fish™ product line of antibodies in order to address the growing needs of the research community for zebrafish specific antibodies, peptides and other products.

Approximately 6.3 million adults—or one fourth of the people in the U.S. with diabetes mellitus—are unaware they have the disease, and this undiagnosed population accounts for an estimated $18 billion in health care costs each year.